Is Benitec Biopharma Inc. overvalued?

Benitec Biopharma Inc. (BNTC) — key valuation metrics and fundamentals.

No verdict

Price

$12.56

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$431.5M

Dividend yield

5.7%

Return on equity

-34.8%

Sector

Healthcare

Fair value compares BNTC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks